Daewoong, Neomics to develop anticancer drug

Daewoong Pharm has recently signed a memorandum of understanding with Neomics Co., a local biopharmaceutical company, to develop, manufacture and commercialize a novel antitumor drug using AIMP2-DX2, a tumor gene that is involved in both cancer generating and suppressing mechanism

Both companies intend to focus their available resources on developing promising candidate compounds against AIM...